Found 15 matching trials
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression PHASE2 SPECIFIC AIMS:
1. To reverse hyperglycemia and insulin dependency in patie...
Show More Location
University of Miami, Diabetes Research Institute
Learn More & Join Trial
Allogenic Islet Cell Transplantation PHASE1 The purpose of this study is to determine the safety of transplanting human...
Show More Status
Active Not Recruiting
Location
The University of Chicago Hospitals
Learn More & Join Trial
MGA031, Sirolimus and Tacrolimus in Islet Transplantation PHASE1 This clinical trial is designed to extend the observations made in our pilo...
Show More Location
University of Minnesota
Learn More & Join Trial
LEA29Y (Belatacept) Emory Edmonton Protocol PHASE2 Type 1 diabetes is an autoimmune disease in which the insulin-producing pan...
Show More Learn More & Join Trial
Islet Cell Transplant for Type 1 Diabetes PHASE2 City of Hope National Medical Center, located in Duarte, CA, is hosting a c...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Islet Transplant for Type 1 or Surgical Diabetes N/A The purpose of this study is to evaluate the safety and efficacy of islet t...
Show More Status
No Longer Available
Location
University of Minnesota
Learn More & Join Trial
Islet Transplantation for Type 1 Diabetes Mellitus PHASE1 The complex program of insulin replacement for type 1 diabetes that is curr...
Show More Learn More & Join Trial
Islet Transplantation in Patients With "Brittle" Type I Diabetes NA The purpose of this study is to learn about the safety of islet transplanta...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes PHASE1 The primary objective of this protocol is to test the safety and efficacy o...
Show More Location
Universtiy of Minnesota
Learn More & Join Trial
An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events EARLY_PHASE1 This study is an open-label, single-arm, non-randomized trial designed to e...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Anhui Medicaluniversity
Learn More & Join Trial